| Title: | A Comparative Study Between Trans-scleral Diode
Cyclophotocoagulation (TSDC) And Combined TSDC
& Intravitreal Bevacizumab Injection In The Treatment
Of Neovascular Glaucoma |
| Full paper | Not Available |
| Abstract: |
Background: Treatment of NVG is achieved by eliminating the stimulus for neovessel formation (VEGF) by destroying the ischemic parts of the retina by PRP, or antagonized by anti- angiogenic agents such as Bevacizumab. |